SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has granted a total of 130,400 restricted stock units (“RSUs”)…
Click here to view original post
Copyright © 2023 Biotech Networks, LLC
